Cargando…

Nuclease-like metalloscissors: Biomimetic candidates for cancer and bacterial and viral infections therapy

Despite the extensive and rapid discovery of modern drugs for treatment of cancer, microbial infections, and viral illnesses; these diseases are still among major global health concerns. To take inspiration from natural nucleases and also the therapeutic potential of metallopeptide antibiotics such...

Descripción completa

Detalles Bibliográficos
Autores principales: Anjomshoa, Marzieh, Amirheidari, Bagher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8816526/
https://www.ncbi.nlm.nih.gov/pubmed/35153301
http://dx.doi.org/10.1016/j.ccr.2022.214417
_version_ 1784645454632321024
author Anjomshoa, Marzieh
Amirheidari, Bagher
author_facet Anjomshoa, Marzieh
Amirheidari, Bagher
author_sort Anjomshoa, Marzieh
collection PubMed
description Despite the extensive and rapid discovery of modern drugs for treatment of cancer, microbial infections, and viral illnesses; these diseases are still among major global health concerns. To take inspiration from natural nucleases and also the therapeutic potential of metallopeptide antibiotics such as the bleomycin family, artificial metallonucleases with the ability of promoting DNA/RNA cleavage and eventually affecting cellular biological processes can be introduced as a new class of therapeutic candidates. Metal complexes can be considered as one of the main categories of artificial metalloscissors, which can prompt nucleic acid strand scission. Accordingly, biologists, inorganic chemists, and medicinal inorganic chemists worldwide have been designing, synthesizing and evaluating the biological properties of metal complexes as artificial metalloscissors. In this review, we try to highlight the recent studies conducted on the nuclease-like metalloscissors and their potential therapeutic applications. Under the light of the concurrent Covid-19 pandemic, the human need for new therapeutics was highlighted much more than ever before. The nuclease-like metalloscissors with the potential of RNA cleavage of invading viral pathogens hence deserve prime attention.
format Online
Article
Text
id pubmed-8816526
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-88165262022-02-07 Nuclease-like metalloscissors: Biomimetic candidates for cancer and bacterial and viral infections therapy Anjomshoa, Marzieh Amirheidari, Bagher Coord Chem Rev Review Despite the extensive and rapid discovery of modern drugs for treatment of cancer, microbial infections, and viral illnesses; these diseases are still among major global health concerns. To take inspiration from natural nucleases and also the therapeutic potential of metallopeptide antibiotics such as the bleomycin family, artificial metallonucleases with the ability of promoting DNA/RNA cleavage and eventually affecting cellular biological processes can be introduced as a new class of therapeutic candidates. Metal complexes can be considered as one of the main categories of artificial metalloscissors, which can prompt nucleic acid strand scission. Accordingly, biologists, inorganic chemists, and medicinal inorganic chemists worldwide have been designing, synthesizing and evaluating the biological properties of metal complexes as artificial metalloscissors. In this review, we try to highlight the recent studies conducted on the nuclease-like metalloscissors and their potential therapeutic applications. Under the light of the concurrent Covid-19 pandemic, the human need for new therapeutics was highlighted much more than ever before. The nuclease-like metalloscissors with the potential of RNA cleavage of invading viral pathogens hence deserve prime attention. Elsevier B.V. 2022-05-01 2022-02-05 /pmc/articles/PMC8816526/ /pubmed/35153301 http://dx.doi.org/10.1016/j.ccr.2022.214417 Text en © 2022 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Review
Anjomshoa, Marzieh
Amirheidari, Bagher
Nuclease-like metalloscissors: Biomimetic candidates for cancer and bacterial and viral infections therapy
title Nuclease-like metalloscissors: Biomimetic candidates for cancer and bacterial and viral infections therapy
title_full Nuclease-like metalloscissors: Biomimetic candidates for cancer and bacterial and viral infections therapy
title_fullStr Nuclease-like metalloscissors: Biomimetic candidates for cancer and bacterial and viral infections therapy
title_full_unstemmed Nuclease-like metalloscissors: Biomimetic candidates for cancer and bacterial and viral infections therapy
title_short Nuclease-like metalloscissors: Biomimetic candidates for cancer and bacterial and viral infections therapy
title_sort nuclease-like metalloscissors: biomimetic candidates for cancer and bacterial and viral infections therapy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8816526/
https://www.ncbi.nlm.nih.gov/pubmed/35153301
http://dx.doi.org/10.1016/j.ccr.2022.214417
work_keys_str_mv AT anjomshoamarzieh nucleaselikemetalloscissorsbiomimeticcandidatesforcancerandbacterialandviralinfectionstherapy
AT amirheidaribagher nucleaselikemetalloscissorsbiomimeticcandidatesforcancerandbacterialandviralinfectionstherapy